Safe Amgen's Dividend? A Practical Investor's Guide
Amgen's dividend has powered income-focused portfolios for years, but regulatory and pricing challenges raise questio...
Discover which stablecoins pay interest safely and how to assess counterparty risk. This guide helps you compare options and reduce exposure while earning yields.
24,010 articlesAmgen's dividend has powered income-focused portfolios for years, but regulatory and pricing challenges raise questio...
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
July brings a tech-driven reshuffle in enterprise budgets. IBM warned of softer Q2 demand as clients pivot toward AI ...
Copart director Daniel Englander recently sold 80,000 shares for about $2.2 million. With CPRT down roughly 40%, inve...
Toast is showing renewed momentum as its growth engine—international expansion, a growing enterprise pipeline, and a ...
A viral clip claiming Gavin Newsom told Atlanta audiences he is just like them sparks questions about trust, framing,...
Solventum wraps up 2025 with meaningful growth and a clearer path to profitability. This article breaks down the numb...
Rigetti Computing has dropped about 70% from its 52-week high. This article breaks down whether the dip offers real u...
Meghan Markle headlines a luxury weekend in Sydney, priced like a premium wellness retreat. This deep dive explains w...
When Micron announced a Taiwanese site acquisition, micron stock popped today and sparked a broader discussion about ...
As homes grow pricier and college costs climb, some parents are choosing to fund down payments for Gen Z rather than ...
A new working paper finds cfos admit privately that AI-related layoffs will rise ninefold this year, yet the total re...